Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Multiple Sclerosis

• Publication date

  2009-08-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1352458509106708PMID 19692432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis

  2009cited by this paper
• Axonal degeneration and progressive neurologic disability in multiple sclerosis

  2009cited by this paper
• Invited Article: Human natural autoantibodies in the treatment of neurologic disease

  2009cited by this paper
• Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.

  2009cited by this paper
• Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.

  2009cited by this paper
• Prediction of neurological diseases by using autoantibodies: wishful thinking come true.

  2008cited by this paper
• How T cells get grip on lipid antigens.

  2008cited by this paper
• The self-organization of lipids and proteins of myelin at the membrane interface. Molecular factors underlying the microheterogeneity of domain segregation.

  2008cited by this paper
• Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease

  2008cited by this paper
• Invariant NKT Cells Regulate Experimental Autoimmune Encephalomyelitis and Infiltrate the Central Nervous System in a CD1d-Independent Manner1

  2008cited by this paper
• Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

  2008cited by this paper
• A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis

  2008influential reference
• Cholesterol domains in cationic lipid/DNA complexes improve transfection.

  2008cited by this paper
• Phosphatidic acid mediates demyelination in Lpin1 mutant mice.

  2008cited by this paper
• In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses12

  2008cited by this paper
• Removal of phospho-head groups of membrane lipids immobilizes voltage sensors of K+ channels

  2008cited by this paper
• Antigen-specific therapies in MS - Current concepts and novel approaches.

  2008cited by this paper
• T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired.

  2008cited by this paper
• A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis

  2008cited by this paper
• Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

  2008cited by this paper
• Prospects of Cell Therapy for Disorders of Myelin

  2008cited by this paper
• Characterization of novel myelin components 3-O-acetyl-sphingosine galactosylceramides by electrospray ionization Q-TOF MS and MS/CID-MS of Li+ adducts.

  2007cited by this paper
• Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6.

  2007cited by this paper
• Autoimmune inflammation from the Th17 perspective.

  2007cited by this paper
• Multiple sclerosis: a complicated picture of autoimmunity

  2007cited by this paper
• Mini Review: Immune Response to Myelin-Derived Sulfatide and CNS-Demyelination

  2007cited by this paper
• Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain

  2007cited by this paper
• The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation

  2007cited by this paper
• T cell recognition of lipids: quo vadis?

  2007cited by this paper
• A recombinant human IgM promotes myelin repair after a single, very low dose

  2007cited by this paper
• Biological markers for multiple sclerosis.

  2007cited by this paper
• Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

  2007cited by this paper
• Multiple sclerosis: Disease biomarkers as indicated by pathophysiology

  2007cited by this paper
• Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.

  2007cited by this paper
• Myelin‐associated glycoprotein (MAG): past, present and beyond

  2007cited by this paper
• Antibodies as biological markers for pathophysiological processes in MS.

  2006cited by this paper
• Lipid microarrays identify key mediators of autoimmune brain inflammation

  2006cited by this paper
• Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment.

  2006cited by this paper
• Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation

  2006cited by this paper
• Glycolipids for natural killer T cells.

  2006cited by this paper
• The Saccharomyces cerevisiae Lipin Homolog Is a Mg2+-dependent Phosphatidate Phosphatase Enzyme*♦

  2006cited by this paper
• How T lymphocytes recognize lipid antigens

  2006cited by this paper
• Molecular mimicry in multiple sclerosis

  2006cited by this paper
• Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

  2006cited by this paper
• Glycolipids for Natural Killer T Cells

  2006cited by this paper
• Mechanisms of lipid-antigen generation and presentation to T cells.

  2006cited by this paper
• Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain white matter

  2006cited by this paper
• Biomarkers in Multiple Sclerosis: Role of Antibodies

  2006cited by this paper
• Glycolipids as immune modulatory tools.

  2006cited by this paper
• Three Mammalian Lipins Act as Phosphatidate Phosphatases with Distinct Tissue Expression Patterns*

  2006cited by this paper
• High cholesterol level is essential for myelin membrane growth

  2005cited by this paper
• Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases.

  2005cited by this paper
• Recognition of lipid antigens by T cells

  2005cited by this paper
• Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis.

  2005cited by this paper
• Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS.

  2005cited by this paper
• Immunological markers in multiple sclerosis: tackling the missing elements

  2005cited by this paper
• Immunoregulation of autoimmunity by natural killer T cells.

  2005cited by this paper
• Molecular Mimicry, Microbial Infection, and Autoimmune Disease: Evolution of the Concept

  2005cited by this paper
• Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

  2005cited by this paper
• Expression of gangliosides on glial and neuronal cells in normal and pathological adult human brain.

  2005cited by this paper
• Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis

  2004cited by this paper
• Regulation of ganglioside biosynthesis in the nervous system Published, JLR Papers in Press, March 1, 2004. DOI 10.1194/jlr.R300020-JLR200

  2004cited by this paper
• Lysolecithin induces demyelination in vitro in a cerebellar slice culture system

  2004cited by this paper
• Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.

  2004influential reference
• The interface of multiple sclerosis and antiphospholipid antibodies.

  2004cited by this paper
• NKT cells: what's in a name?

  2004cited by this paper
• Natural killer T cells as targets for immunotherapy of autoimmune diseases

  2004cited by this paper
• Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody.

  2004cited by this paper
• Going both ways: immune regulation via CD1d-dependent NKT cells.

  2004cited by this paper
• Prevention of Autoimmunity by Targeting a Distinct, Noninvariant CD1d-reactive T Cell Population Reactive to Sulfatide

  2004cited by this paper
• Principles of Autoantibodies as Disease-specific Markers

  2004cited by this paper
• A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2‐weighted spinal cord MRI in a virus‐induced murine model of MS

  2004cited by this paper
• Role of lipid interactions in autoimmune demyelination.

  2004cited by this paper
• [Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].

  2004cited by this paper
• Two new trifunctional antibodies for the therapy of human malignant melanoma

  2004cited by this paper
• Lysosomal Glycosphingolipid Recognition by NKT Cells

  2004cited by this paper
• A biased Valpha24+ T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease.

  2003cited by this paper
• Activation of invariant NKT cells by αGalCer administration protects mice from MOG35–55‐induced EAE: critical roles for administration route and IFN‐γ 

  2003cited by this paper
• Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma

  2003cited by this paper
• Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.

  2003cited by this paper
• Structural Features of the Acyl Chain Determine Self-phospholipid Antigen Recognition by a CD1d-restricted Invariant NKT (iNKT) Cell*

  2003cited by this paper
• Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission.

  2003cited by this paper
• Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease

  2003cited by this paper
• Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis.

  2003cited by this paper
• [Myelin oligodendrogliocyte glycoprotein: the structure, functions, role in pathogenesis of demyelinating disorders].

  2003cited by this paper
• Regulatory lymphocytes: Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity

  2003cited by this paper
• Cross‐reactivity with myelin basic protein and human herpesvirus‐6 in multiple sclerosis

  2003cited by this paper
• Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair.

  2003cited by this paper
• Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies

  2003cited by this paper
• Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis.

  2003influential reference
• Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells

  2003cited by this paper
• Presentation of the Same Glycolipid by Different CD1 Molecules

  2002cited by this paper
• Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic‐progressive demyelinating disease

  2002cited by this paper
• Oligoclonal bands and antibody responses in Multiple Sclerosis

  2002cited by this paper
• Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

  2002cited by this paper
• Galactolipids are molecular determinants of myelin development and axo-glial organization.

  2002cited by this paper
• Immunopathogenesis of multiple sclerosis: MBP and beyond

  2002cited by this paper
• 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide.

  2002influential reference
• Human antibodies accelerate the rate of remyelination following lysolecithin‐induced demyelination in mice

  2002cited by this paper
• Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration

  2002cited by this paper

• Presence and relevance of serum anti-C1P IgG antibodies in relapsing-remitting multiple sclerosis

  2025cites this paper
• Metabolic reprogramming of glial cells: Fatty acid pathways as regulators of remyelination in multiple sclerosis.

  2025cites this paper
• Identification of hsa_circ_0018905 as a New Potential Biomarker for Multiple Sclerosis

  2024cites this paper
• Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients

  2023cites this paper
• Sphingolipid Players in Multiple Sclerosis: Their Influence on the Initiation and Course of the Disease

  2022cites this paper
• T cells from MS Patients with High Disease Severity Are Insensitive to an Immune-Suppressive Effect of Sulfatide

  2022cites this paper
• Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity

  2021cites this paper
• Quantification of Oligodendrocytes and Myelin in Human iPSC-Derived 3D Brain Cell Cultures (BrainSpheres)

  2021cites this paper
• Oligodendroglial glycolipids in (Re)myelination: implications for multiple sclerosis research.

  2021cites this paper
• Distinctive sphingolipid patterns in chronic multiple sclerosis lesions

  2020cites this paper
• Serum ceramide levels are altered in multiple sclerosis

  2020cites this paper
• The role of Sphingolipids in myelination and myelin stability and their involvement in childhood and adult demyelinating disorders

  2020cites this paper
• The role of basal autophagy in oligodendrocyte development

  2019cites this paper
• Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges

  2019cites this paper
• Autoimmunity in multiple sclerosis: role of sphingolipids, invariant NKT cells and other immune elements in control of inflammation and neurodegeneration.

  2018cites this paper
• Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis

  2018cites this paper
• Regulatory B cells and advances in transplantation

  2018cites this paper
• Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis.

  2017cites this paper
• Multiple sclerosis: Presence of serum antibodies to lipids and predominance of cholesterol recognition

  2017cites this paper
• Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 – 2014)

  2015cites this paper
• The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane

  2015cites this paper
• Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis

  2015cites this paper
• Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.

  2015cites this paper
• Targets of the humoral autoimmune response in multiple sclerosis.

  2014cites this paper
• Enhanced uptake of multiple sclerosis-derived myelin by THP-1 macrophages and primary human microglia

  2014cites this paper
• Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

  2013cites this paper
• Implications of Lymphocyte Anergy to Glycolipids in Multiple Sclerosis (MS): iNKT Cells May Mediate the MS Infectious Trigger

  2013cites this paper
• Invariant Natural Killer T-cell anergy to endogenous myelin acetyl-glycolipids in multiple sclerosis.

  2013cites this paper
• Myelin Recovery in Multiple Sclerosis: The Challenge of Remyelination

  2013cites this paper
• Signaling and Regulatory Functions of Bioactive Sphingolipids as Therapeutic Targets in Multiple Sclerosis

  2012cites this paper
• Will the real multiple sclerosis please stand up?

  2012cites this paper
• Will the real multiple sclerosis please stand up?

  2012cites this paper
• Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.

  2012cites this paper
• Lipid raft formation and peptide-lipid interactions in myelin model membranes

  2012cites this paper
• Evidence for membrane flow through pores in stacked phospholipid membranes

  2012cites this paper
• The innate immune system in demyelinating disease

  2012cites this paper
• Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?

  2012cites this paper
• Animal Models of Multiple Sclerosis

  2011cites this paper
• Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.

  2011cites this paper
• The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis

  2011cites this paper
• The Lipid Sulfatide Is a Novel Myelin-Associated Inhibitor of CNS Axon Outgrowth

  2011cites this paper
• Oxysterol derivatives of cholesterol in neurodegenerative disorders.

  2011cites this paper
• Myelin and multiple sclerosis

  2011cites this paper
• Multiple Sclerosis: Autoimmune Disease or Autoimmune Reaction?

  2010cites this paper
• Sphingolipids in Multiple Sclerosis

  2010cites this paper
• Heterogeneity in Multiple Sclerosis: Scratching the Surface of a Complex Disease

  2010cites this paper
• Identifying targets for autoantibodies in CNS inflammation: Strategies and achievements

  2010cites this paper
• Biomarkers for multiple sclerosis.

  2010cites this paper
• Animal models of multiple sclerosis—Potentials and limitations

  2010cites this paper
• Is the inner ear an orphan organ? Is there a need for further translational research?

  2009cites this paper